相关实验视频

Updated: Jun 11, 2025

Bile Duct Ligation in Mice: Induction of Inflammatory Liver Injury and Fibrosis by Obstructive Cholestasis

Bile Duct Ligation in Mice: Induction of Inflammatory Liver Injury and Fibrosis by Obstructive Cholestasis

Published on: February 10, 2015

肝纤维化预防和治疗的新目标:华堡效应

Meng Pan¹, Huanyu Li², Xiaoyan Shi¹

¹College of Basic Medical Sciences, Shaanxi University of Chinese Medicine, 712046 Xianyang, Shaanxi, China.

Frontiers in bioscience (Landmark edition)

|September 30, 2024

概括

华堡效应是一种代谢变化,通过激活肝星细胞和极化肝细胞巨,驱动肝纤维化. 针对这种效应为肝纤维化提供了新的治疗策略.

科学领域:

生物化学生物化学
细胞生物学细胞生物学
病理学病理学病理学

背景情况:

肝纤维化是一个重要的全球健康问题.
代谢重编程,特别是华堡效应,越来越多地被认为在肝纤维化进展中的作用.
华堡效应影响了参与肝损伤和修复的关键细胞过程.

研究的目的:

审查华堡效应在肝纤维化中的作用.
阐明华堡效应影响肝星细胞激活和肝细胞巨细胞两极化的机制.
讨论针对华堡效应用于肝纤维化治疗的治疗策略.

主要方法:

文献综述侧重于代谢重编程和肝纤维化.
对详细说明华堡效应对细胞通路的影响的研究进行分析.
对针对糖溶性蛋白质的药物进行临床前数据的检查.

主要成果:

华堡效应通过增强肝星细胞激活来促进肝纤维化.
这种代谢转变也推动了亲纤维性肝细胞巨的两极分化.
准关键的糖解蛋白在肝纤维化的临床前模型中显示出有前途的结果.

结论:

华堡效应是肝纤维化的一个关键驱动因素.
通过华堡效应调节细胞代谢,提供了一个可行的治疗途径.
对糖解抑制剂的进一步研究可能会导致肝纤维化的有效临床治疗.

关键词:

华堡效应是什么意思? 华堡效应有氧糖解有氧糖解.肝脏纤维化肝脏纤维化肝脏的巨细胞.肝脏的恒星细胞.

更多相关视频

Optimized Analysis of In Vivo and In Vitro Hepatic Steatosis

Optimized Analysis of In Vivo and In Vitro Hepatic Steatosis

Published on: March 11, 2017

Measurement of the Hepatic Venous Pressure Gradient and Transjugular Liver Biopsy

Measurement of the Hepatic Venous Pressure Gradient and Transjugular Liver Biopsy

Published on: June 18, 2020

相关概念视频

Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists

Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists

Endothelins (ETs) are potent vasoactive peptides critical in the human body's various physiological and pathological processes. One of the most promising therapeutic strategies for treating pulmonary arterial hypertension (PAH) involves counteracting the effects of these endothelins using a class of drugs known as endothelin receptor antagonists.
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...

Hepatic Drug Clearance: Effect of Protein Binding

Hepatic Drug Clearance: Effect of Protein Binding

Hepatic clearance is influenced by protein binding based on the drug's extraction ratio. Drugs with high extraction ratios are considered flow-limited and remain unaffected by protein binding during hepatic clearance. On the other hand, drugs with low extraction ratios may be impacted by plasma protein binding, although the extent of this influence depends on the fraction of the drug bound.
For low-extraction-ratio drugs that are less than 80% protein-bound, minor changes in protein binding...